https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-04-18 / Breast 2015 Aug;24(4):418-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-04-18 / Breast 2015 Aug;24(4):418-252015-04-18 00:00:002015-04-18 00:00:00Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-04-01 / Anticancer Res. 2015 Apr;35(4):2299-303
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-04-01 / Anticancer Res. 2015 Apr;35(4):2299-3032015-04-01 00:00:002015-04-01 00:00:00Hyperthermia combined with chemotherapy for patients with residual or recurrent oesophageal cancer after definitive chemoradiotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-04-01 / Breast Care (Basel) 2015 Apr;10(2):109-16
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-04-01 / Breast Care (Basel) 2015 Apr;10(2):109-162015-04-01 00:00:002015-04-01 00:00:00Hyperthermia Is Now Included in the NCCN Clinical Practice Guidelines for Breast Cancer Recurrences: An Analysis of Existing Data
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-03-01 / Tumori 2015 Mar-Apr;101(2):e54-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-03-01 / Tumori 2015 Mar-Apr;101(2):e54-62015-03-01 00:00:002019-02-15 09:37:55Concomitant trimodality therapy of re-irradiation, chemotherapy and regional hyperthermia for a pretreated inoperable sarcoma recurrence
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-02-26 / J. Nucl. Med. 2015 Apr;56(4):530-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-02-26 / J. Nucl. Med. 2015 Apr;56(4):530-72015-02-26 00:00:002019-02-15 09:37:54PET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-02-20 / Cancer Res. 2015 Apr;75(8):1760-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-02-20 / Cancer Res. 2015 Apr;75(8):1760-92015-02-20 00:00:002019-02-15 09:00:11Hyperthermia Sensitizes Glioma Stem-like Cells to Radiation by Inhibiting AKT Signaling
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-02-12 / Cell Death Dis 2015 Feb;6:e1633
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-02-12 / Cell Death Dis 2015 Feb;6:e16332015-02-12 00:00:002019-02-15 09:18:01Hyperthermia restores apoptosis induced by death receptors through aggregation-induced c-FLIP cytosolic depletion
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-12-01 / Int J Hyperthermia 2014 Dec;30(8):531-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-12-01 / Int J Hyperthermia 2014 Dec;30(8):531-92014-12-01 00:00:002019-02-15 09:17:07Local tumour hyperthermia as immunotherapy for metastatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-21 / J. Cell. Mol. Med. 2015 Feb;19(2):340-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-21 / J. Cell. Mol. Med. 2015 Feb;19(2):340-502014-10-21 00:00:002014-10-21 00:00:00Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-15 / Mol Med Rep 2015 Jan;11(1):327-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-15 / Mol Med Rep 2015 Jan;11(1):327-322014-10-15 00:00:002019-02-15 09:18:18Inhibition of cell proliferation by mild hyperthermia at 43˚C with Paris Saponin I in the lung adenocarcinoma cell line PC-9
